fails to address access, equity and the practices that already sustain care in real life.

product quality has left out guarantees for the quality of life for the thousands of patients who will use these treatments. Although this new legislation guarantees technical standards, it does not constitute a genuine public policy on medical cannabis. It “legalises” a product, but once again

rules, supporting Swiss production, ensuring youth protection, and setting moderate taxes to create a safe, competitive legal market.

Just a lot of people not understanding the vary basics of what cannabis is. And a lot less people trying to bluff their way in